Chlorphenamine Maleate

马来酸氯苯那敏

Report date: 2023/08/09 18:25:38
NME

Base Information

Drug NameChlorphenamine Maleate
Drug Alias NameClorfenamina马来那敏扑尔敏ChlorphenaminumClofeniramina Maleate +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)HypersensitivityUrticaria +[13] 
Global Approved IndicationsHypersensitivityUrticariaPruritus +[8] 
Approved Indications in ChinaHypersensitivityUrticariaPruritus +[6] 
Original Approved Country/TerritoryUnited States
Original Approved Date1949/07/13
Country/TerritoryUnited StatesHondurasMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSchering Pharma
China Registration ClassN/A

Develop Information

Active CompaniesAuburn UniversityDr. Ferrer BioPharmaTianjin Huajin Pharmaceutcial Co Ltd +[8] 
Inactive CompaniesWyeth LlcMagna Pharmaceuticals IncSchering Ag +[5] 
Active IndicationsCoronavirus Disease 2019 (COVID-19)HypersensitivityUrticaria +[9] 
Inactive IndicationsConjunctivitisRhinitis, AllergicNasal Obstruction +[4] 

Other Information

ATC CodeR06AB04
Related LinksWikipediaDrugBankKEGG